Capital Analysts, LLC - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 251 filers reported holding CANTEL MEDICAL CORP in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Capital Analysts, LLC ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q4 2019$425,000
-1.8%
5,990
+3.4%
0.04%
-8.7%
Q3 2019$433,000
-8.3%
5,795
-1.0%
0.05%
-9.8%
Q2 2019$472,000
+10.8%
5,855
-8.1%
0.05%
+4.1%
Q1 2019$426,000
+17.0%
6,370
+30.4%
0.05%
+2.1%
Q4 2018$364,000
-99.9%
4,886
-47.1%
0.05%0.0%
Q3 2018$425,791,000
+94310.4%
9,240
+101.5%
0.05%
-11.1%
Q2 2018$451,000
-18.4%
4,585
-7.6%
0.05%
-20.6%
Q1 2018$553,000
+8.4%
4,9600.0%0.07%
+6.2%
Q4 2017$510,000
+12.3%
4,960
+2.8%
0.06%
+4.9%
Q3 2017$454,000
-99.9%
4,8250.0%0.06%
+13.0%
Q2 2017$375,922,000
+11.6%
4,825
+14.7%
0.05%
+1.9%
Q1 2017$336,827,000
+92689.8%
4,205
-8.9%
0.05%
-17.2%
Q4 2016$363,000
-99.9%
4,6150.0%0.06%
-5.9%
Q3 2016$359,877,000
+16.0%
4,615
+2.2%
0.07%
+9.7%
Q2 2016$310,315,000
-3.7%
4,5150.0%0.06%
-4.6%
Q1 2016$322,190,000
+36.8%
4,515
+19.1%
0.06%
+35.4%
Q4 2015$235,510,000
-45.2%
3,790
-50.0%
0.05%
-41.5%
Q3 2015$429,786,000
+120.0%
7,580
+108.2%
0.08%
+105.0%
Q2 2015$195,358,000
+22.6%
3,640
+8.5%
0.04%
+21.2%
Q1 2015$159,362,000
-2.8%
3,355
-11.5%
0.03%
-8.3%
Q4 2014$163,955,000
+16.6%
3,790
-7.3%
0.04%
+9.1%
Q3 2014$140,614,0004,0900.03%
Other shareholders
CANTEL MEDICAL CORP shareholders Q3 2019
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,383,325$136,064,00048.67%
Brown Capital Management 3,345,000$329,014,0003.38%
Kimelman & Baird, LLC 206,142$20,276,0002.66%
Conestoga Capital Advisors, LLC 690,673$67,935,0002.19%
WASATCH ADVISORS LP 1,772,992$174,391,0002.10%
Ranger Investment Management 280,989$27,638,0001.93%
Freedom Day Solutions, LLC 21,938$2,158,0001.76%
CAPITAL INSIGHT PARTNERS, LLC 17,853$1,756,0001.44%
Geller Advisors LLC 22,700$2,233,0000.97%
Sapphire Star Partners LP 8,607$846,0000.87%
View complete list of CANTEL MEDICAL CORP shareholders